NCT04316351 2020-07-23
Efficacy and Safety of Toripalimab (JS001) Combined With Pemetrexed and Anlotinib for Patients With T790M Positive Non-Small Cell Lung Cancer After Osimertinib Resistance
Guangzhou Institute of Respiratory Disease
Phase 2 Unknown